Profil
Aaron Small worked as the Vice President-Global Development Sales at Recipharm AB from 2012 to 2021.
He completed his undergraduate degree from Shippensburg University of Pennsylvania in 2009, followed by an MBA from the University of Phoenix in 2013.
He completed his graduate degree from Temple University Graduate School in 2019.
Anciens postes connus de Aaron Small
| Sociétés | Poste | Fin |
|---|---|---|
| RECIPHARM AB (PUBL) | Sales & Marketing | 01/11/2021 |
Formation de Aaron Small
| Temple University Graduate School | Graduate Degree |
| University of Phoenix | Masters Business Admin |
| Shippensburg University of Pennsylvania | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Recipharm AB
 Recipharm AB BiotechnologyHealth Technology Recipharm AB engages in the manufacture of pharmaceuticals and contract development services for pharmaceutical companies. It operates through the following segments: Manufacturing Sterile and Inhalation (MFG-SI); Manufacturing Solids and Others (MFG-SO); Development and Technology (D&T); and Others and Eliminations. The MFG-SI segment includes manufacturing of products on behalf of pharmaceutical companies and covers sterile and inhalation technologies as well as liquid vials and ampoules, lyophilisates, blow-fill-seal products, and inhalation. The MFG-SO segment produces products on behalf of pharmaceutical companies and covers tablets, capsules, semi-solids, and non-sterile liquids. The D&T segment focuses on pharmaceutical development services. The company was founded by Lars Rickard Backsell and Thomas Bengt Eldered in 1995 and is headquartered in Stockholm, Sweden. | Health Technology |
